ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $5.85 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2024-03-12
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $5.85, a 28.75% decline from fiscal 2022.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $8.21, a 13.40% decline from fiscal 2021.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $9.48, a 327.03% increase from fiscal 2020.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $2.22, a 29.07% increase from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2023-12-31 | $5.85 10-K · filed 2024-03-12 | |
| 2022-12-31 | $8.21 10-K · filed 2023-03-01 | |
| 2021-12-31 | $9.48 10-K · filed 2023-03-01 | |
| 2020-12-31 | $2.22 10-K · filed 2022-03-09 | |
| 2019-12-31 | $1.72 10-K · filed 2021-03-22 | |
| 2018-12-31 | $0.95 10-K · filed 2020-03-27 | |
| 2017-12-31 | $0.85 10-K · filed 2019-04-01 | |
| 2016-12-31 | $3.01 10-K · filed 2018-03-21 | |
| 2015-12-31 | $18.77 10-K · filed 2017-03-09 | $0.47 10-K · filed 2016-03-25 |
| 2014-12-31 | $0.63 10-K · filed 2016-03-25 | $0.54 10-K · filed 2015-03-17 |
| 2013-12-31 | $0.63 10-K · filed 2015-03-17 | |
| 2012-12-31 | $0.48 10-K · filed 2014-03-28 | |
| 2010-12-31 | $0.83 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |